Oncotarget

Research Papers:

Prognostic significance of subclassification of stage IIB lung cancer: a retrospective study of 226 patients

Nanchang Yin, Minwen Ha, Yu Liu, Huizi Gu, Zetian Zhang and Wei Liu _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:45777-45783. https://doi.org/10.18632/oncotarget.17405

Metrics: PDF 1085 views  |   HTML 1731 views  |   ?  


Abstract

Nanchang Yin1, Minwen Ha2, Yu Liu3, Huizi Gu4, Zetian Zhang5 and Wei Liu2

1Department of Thoracic Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China

2Department of Medical Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China

3Department of Thoracic Surgery, Liaoning Cancer Hospital and Institute, Shenyang 110042, China

4Department of Internal Neurology, The Second Hospital of Dalian Medical University, Dalian 116027, China

5Shenyang Yike Biotechnology Co., Ltd, Shenyang 110000, China

Correspondence to:

Wei Liu, email: [email protected]

Keywords: lung cancer, lymph node metastasis, T category, prognosis, stage IIB

Abbreviations: AJCC/UICC: American Joint Committee on Cancer/Union for International Cancer Control; TNM: tumor-node-metastasis

Received: January 30, 2017    Accepted: April 03, 2017    Published: April 25, 2017

ABSTRACT

We investigated the prognostic significance of subclassification of stage IIB lung cancer according to the eighth tumor-node-metastasis (TNM) classification. To this purpose, the prognostic outcomes of 226 stage IIB lung cancer patients who underwent surgery without adjuvant therapies between 2001 and 2010 were evaluated retrospectively based on the eighth TNM classification. Of the 226 patients, 23, 30, 118 and 55 had pT1b, pT1c, pT2a, and pT2b stage cancers, respectively. Their 5-year survival rates were 67%, 33%, 21%, and 27%, respectively. There was no significant difference in the 5-year survival between T1b and T1c, between T1c and T2a, and between T2a and T2b (p = 0.128, 0.105, and 0.403, respectively). There were significant differences in the 5-year survival between T1b and T2a, between T1b and T2b, and between T1c and T2b (p = 0.005, 0.002, and 0.042, respectively). The 5-year survival of patients with pleural invasion and vessel invasion was significantly worse than that of their counterparts (p = 0.009 and <0.001, respectively). Subclassification of stage IIB lung cancer is of prominent prognostic significance. It is recommended that the current stage be subclassified, in order to more accurately predict the prognosis of patients.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 17405